Seed-backed growth HealNow, rebranded as Tabz, has secured a $5.5 million seed round from multiple venture investors in 2023, signaling strong investor confidence and potential for rapid product expansion and partner-led sales opportunities in pharmacy payments and commerce.

Pharmacy focus Positioned as the pharmacy commerce standard handling payments, messaging, refills, and revenue, Tabz serves a wide range of pharmacy customers from independents to enterprise hubs, suggesting high demand for scalable payments integrations across pharmacy networks.

Financial potential Reported annual revenue in the range of $10M–$25M with a lean employee base, indicating a scalable platform with room for upsell into larger pharmacy networks and multi-site operators seeking better payment and workflow efficiencies.

Tech stack leverage Utilizes a broad enterprise tech stack (Salesforce, Snowflake, Rippling, iCIMS) which can ease integration with pharmacy management systems and enable joint go-to-market motions with customers already using these platforms.

Growth channels Recent press coverage highlights multiple investors backing HealNow Tabz; this momentum can be leveraged to pursue co-selling, channel partnerships, and customer referrals within the pharmacy ecosystem to accelerate market penetration.